Olsar-H 40 Tablet is a combination antihypertensive medication containing Olmesartan Medoxomil 40 mg and Hydrochlorothiazide 12.5 mg. Olmesartan Medoxomil is an angiotensin II receptor blocker (ARB) that selectively inhibits the binding of angiotensin II to the AT1 receptor, thereby reducing vasoconstriction and aldosterone secretion, leading to decreased blood pressure. Hydrochlorothiazide is a thiazide diuretic that promotes the excretion of sodium and water by inhibiting sodium reabsorption in the distal renal tubules, contributing to a reduction in plasma volume and peripheral resistance. This synergistic combination effectively manages hypertension in patients who require more than monotherapy to achieve optimal blood pressure control. Olsar-H 40 is indicated for the treatment of essential hypertension and may reduce the risk of cardiovascular events associated with high blood pressure. The medication should be administered once daily, with or without food, as directed by a healthcare professional. Caution is advised in patients with renal or hepatic impairment, electrolyte imbalances, or hypersensitivity to sulfonamides. Regular monitoring of blood pressure, renal function, and electrolytes is recommended during therapy to ensure safety and efficacy. Olsar-H 40 should not be used during pregnancy due to potential fetal toxicity.